STOCK TITAN

Tabula Rasa HealthCare Schedules First Quarter 2023 Earnings Conference Call

Tabula Rasa HealthCare (TRHC) has scheduled a conference call and webcast for May 9, 2023, at 8:30 a.m. EDT to discuss its first quarter 2023 financial results.

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags
conferences earnings

Rhea-AI Summary

Tabula Rasa HealthCare (TRHC) has scheduled a conference call and webcast for May 9, 2023, at 8:30 a.m. EDT to discuss its first quarter 2023 financial results. The financial results will be released after market close on May 8, 2023. TRHC focuses on medication safety solutions, utilizing proprietary technology like MedWise® to optimize medication regimens, minimize adverse drug events, and reduce healthcare costs. Their clinical tele-pharmacy network enhances patient care nationwide, and their services are trusted by health plans and at-risk provider groups for value-based care initiatives.

Loading...
Loading translation...

Positive

  • Scheduled conference call for May 9, 2023, to discuss Q1 financial results.
  • Focus on medication safety solutions using proprietary technology.
  • Tele-pharmacy network enhances patient care nationwide.

Negative

  • None.
Argus Session date unavailable
-0.38% session move Open Argus
Details

News Market Reaction – TRHC

The recorded move for TRHC in the trading session of this news was -0.38%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MOORESTOWN, N.J., April 26, 2023 /PRNewswire/ -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC), will hold a conference call and webcast to discuss its first quarter 2023 financial results Tuesday, May 9, 2023 at 8:30 a.m. EDT. The Company's financial results for the first quarter 2023 ended March 31, 2023, will be released after the close of the market Monday, May 8, 2023.

Those interested in participating via webcast in listen-only mode can access the event here. For participants who would like to participate via telephone, please register here to receive the dial-in number along with a unique PIN number that is required to access the call. A replay of the earnings call will be available via webcast at the Investor Relations section of TRHC's website (ir.tabularasahealthcare.com).

About Tabula Rasa HealthCare

Tabula Rasa HealthCare provides medication safety solutions that empower healthcare professionals and consumers to optimize medication regimens, combating medication overload and reducing adverse drug events. TRHC's proprietary technology solutions, including MedWise®, improve patient outcomes, reduce hospitalizations, and lower healthcare costs. TRHC's extensive clinical tele-pharmacy network improves care for patients nationwide. Its solutions are trusted by health plans and at-risk provider groups to help drive value-based care. For more information, visit TRHC.com.

 

 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/tabula-rasa-healthcare-schedules-first-quarter-2023-earnings-conference-call-301808468.html

SOURCE Tabula Rasa HealthCare, Inc.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When will Tabula Rasa HealthCare release its Q1 2023 financial results?

Tabula Rasa HealthCare will release its Q1 2023 financial results on May 8, 2023, after market close.

What time is the Tabula Rasa HealthCare earnings conference call?

The earnings conference call is scheduled for May 9, 2023, at 8:30 a.m. EDT.

What is the focus of Tabula Rasa HealthCare's business?

Tabula Rasa HealthCare focuses on providing medication safety solutions to optimize medication regimens and reduce adverse drug events.

Keep reading